Related Experiment Video

Updated: May 20, 2026

Nanoparticle-mediated siRNA Gene-silencing in Adult Zebrafish Heart
09:12

Nanoparticle-mediated siRNA Gene-silencing in Adult Zebrafish Heart

Published on: July 29, 2018

Therapeutic implications of small interfering RNA in cardiovascular diseases

Suchi Raghunathan1, Bhoomika M Patel

  • 1Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India.

Fundamental & Clinical Pharmacology
|July 6, 2012
PubMed

Insights

Small interfering RNA (siRNA) offers a promising therapeutic approach for cardiovascular diseases (CVDs). This review explores siRNA mechanisms, delivery, and applications for treating conditions like hypertension and heart failure.

Area of Science:

  • Biochemistry and Molecular Biology
  • Genetics and Genomics
  • Cardiology and Cardiovascular Medicine

Background:

  • Cardiovascular diseases (CVDs) represent a significant global health and economic challenge, particularly in low- and middle-income countries.
  • Effective CVD management necessitates population-wide risk reduction and targeted strategies for high-risk individuals or those with existing conditions.

Purpose of the Study:

  • To review the mechanism of RNA interference (RNAi) and its associated delivery systems.
  • To explore the therapeutic potential of small interfering RNA (siRNA) in treating various cardiovascular diseases.

Main Methods:

  • Literature review focusing on RNAi mechanisms and siRNA delivery technologies.
  • Analysis of current research on siRNA applications for cardiovascular conditions such as hypertension, atherosclerosis, and heart failure.

Main Results:

  • Small interfering RNA (siRNA) acts as a functional mediator for gene expression regulation.
  • siRNA demonstrates potential as a therapeutic agent for diverse cardiovascular diseases.

Conclusions:

  • siRNA-based therapies hold significant promise for the future treatment of cardiovascular diseases.
  • Further research into siRNA delivery systems and therapeutic applications is warranted to combat the global burden of CVDs.

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...